Previous studies have demonstrated a dramatic induction of inflammatory gene expression in livers from mice fed a high fat, high cholesterol diet containing cholate after 3-5 weeks. To determine the contribution of cholate in mediating these inductions, C57BL/6 mice were fed a chow diet supplemented with increasing concentrations of cholic acid (CA) for 5 days. A dose dependent induction in the hepatic levels of TNFα, VCAM-1, ICAM-1 and SAA-2 mRNA were observed. As positive controls, a dose dependent repression of cholesterol 7α-hydroxylase (CYP7A1) and a dose dependent induction of SHP expression were also observed suggesting that FXR was activated. In addition, ICAM-1 and SHP mRNA levels were also induced in primary human hepatocytes when treated with chenodeoxycholic acid (CDCA), or GW4064, a FXRselective agonist. The involvement of FXR in CA induced inflammatory gene expression was further investigated in the human hepatic cell line, HepG2. Both ICAM-1 and SHP expression were induced in a dose-and time-dependent manner by treatment with the FXR-selective agonist GW4064. Moreover, the induction of ICAM-1 by GW4064 was inhibited by the FXR antagonist guggulsterone or with transfection of FXR siRNA. Finally, the activity of FXR was mapped to a RARE site containing an imbedded FXRE on the human ICAM-1 promoter and FXR and RXR were demonstrated to bind to this site. Finally, FXR-mediated activation of ICAM-1 could be further enhanced by TNFα  co-treatment in hepatocytes suggesting a potential cooperation between cytokine and bile acid signaling pathways during hepatic inflammatory events.
Introduction
Bile acids are amphipathic detergents necessary for the digestion and absorption of fat-soluble nutrients. Bile acids are synthesized in the liver by either a neutral or classic pathway resulting in formation of cholic acid (CA) or by an acidic or alternative pathway leading to the synthesis of chenodeoxycholic acid (CDCA). In humans, the classic biosynthetic pathway predominates via the rate-limiting enzyme cholesterol-7α-hydroxylase (CYP7A1). After their synthesis, bile acids are excreted to the intestine where they facilitate the absorption of dietary lipid and lipid soluble nutrients. In addition, bile acids are also important in the excretion of cholesterol and toxic metabolites. The biosynthesis of bile acids from cholesterol is the most significant pathway for the elimination of cholesterol from the body.
It has been recently demonstrated that bile acids are the physiologic ligands for the farnesoid X receptor (FXR) (24, 38). FXR is expressed mainly in tissues that are exposed to high concentrations of bile acids including the liver and intestine (24, 38).
Activated FXR binds to the promoters of its target genes typically via an IR-1 element and enhances the transcription of these genes, including small heterodimer partner (SHP) (11, 33), bile salt export pump (BSEP) and ileal bile acid binding protein (IBABP) (1, 3, 12, 23). The induction of SHP by FXR results in the negative regulation of bile acid synthesis through the regulation of CYP7A1 and sterol 12α-hydroxylase (CYP8B1) (11, 22, 42) . Thus, FXR is an important regulator for bile acid homeostasis and inactivation of FXR in mice results in elevated serum bile acids and cholesterol, increased triglyceride levels, increased hepatic cholesterol and a pro-atherogenic serum lipoprotein profile (17) .
While the role of bile acids in regulation of bile acid and lipid homeostasis has been well established, its potential role in inflammation has not been defined. There have been a number of reports in the literature suggesting a link between bile acids and inflammation. When accumulated in high concentrations, hydrophobic bile acids can result in an inflammatory phenotype as evidenced during cholestasis (13). The induction of pro-inflammatory genes such as epidermal growth factor (EGF), transforming growth factor β 1 (TGFβ1), tumor necrosis factor α (TNFα), interleukin 1 (IL-1), and intercellular adhesion molecule 1 (ICAM-1) have been demonstrated in experimental models of cholestasis after bile duct ligation resulting in neutrophil-induced liver injury (14, 30) . In addition, prior to the development of genetically modified mice that are prone to atherosclerosis, cholate supplementation to a high fat, high cholesterol diet was necessary to induce consistent aortic lesion formation in C57BL/6 mice (28). This diet has also been shown to induce the expression of a number of inflammatory genes in the liver including serum amyloid A 2 (SAA-2), monocyte chemotactic protein 1 (MCP-1), vascular adhesion molecule 1 (VCAM-1), TNFα, and regulated on activation normal T cell expressed and secreted (RANTES) (9, 18) with the induction of VCAM-1 specifically being attributed to the presence of cholate (36).
The mechanism by which bile acids could be inducing hepatic and vascular wall inflammation is unclear. The inflammation induced by prolonged exposure to high levels of bile acids could simply be due to its associated cytotoxicity (7). Alternatively, bile acids could elicit their pro-inflammatory phenotype through activation of kinase pathways including protein kinase C (34), extracellular signal-regulated kinase (31), or cjun N-terminal kinase (15) . In addition, bile acids can stimulate cytokine production in macrophages that then can modulate adjacent hepatocytes (26). In this report, we demonstrate a novel pathway in which bile acids can induce inflammatory gene expression through direct FXR signaling.
In this study, we demonstrate that treatment of C57BL/6 mice with CA results in the induction of ICAM-1, VCAM-1, TNFα and SAA-2. Moreover, in HepG2 cells, ICAM-1 expression was induced by the synthetic FXR agonist, GW4064 (25) in a dose and time dependent manner. The induction of ICAM-1 by GW4064 could be antagonized by treatment with the FXR antagonist guggulsterone or through inhibition of FXR expression by siRNA. FXR was demonstrated to directly interact with a RARE/FXRE site within the human ICAM-1 promoter. Finally, we demonstrate that the activation of ICAM-1 by liganded FXR could be further enhanced by co-treatment with cytokines suggesting a potential cooperation between the two signaling pathways during inflammatory events.
MATERIALS AND METHODS
Mice. Male C57BL/6 mice (16-20g) (Taconic) were separated into groups of 8. The mice were fed a chow diet or high fat diet (20% fat, 0.15% cholesterol) supplemented with CA (0.1-1%) as indicated for up to 5 weeks. At the end of the experimental period, the liver was dissected and immediately frozen in liquid nitrogen. Liver total RNA was prepared by using Trizol reagent (Gibco BRL) and further purified using RNeasy kit (Qiagen). Gene expression analysis was performed using real time RT-PCR as described previously (9).
Cell Culture. Primary human hepatocytes cultured in a 24-well plate (Cambrex Inc) were treated immediately upon arrival. HepG2 cells were maintained in growth media (DMEM; Gibco BRL) supplemented with heat-inactivated 10% FBS, 1% Glutamax, 1% MEM non-essential amino acids, 100 U/ml penicillin and 100 µg/ml streptomycin. All cells were maintained in 37°C in a 5% CO 2 incubator. The cells were seeded in at Western Blots. The HepG2 cell protein extracts were separated on a 4-15% SDS-PAGE and then transferred to polyvinylidine difluoride membrane. The membrane was blotted using a rabbit anti-ICAM-1 or goat anti-Actin antibody (1:1000 dilution, SC-7891 and SC-1616, respectively, Santa Cruz Biotechnology). Secondary HRP labeled anti-rabbit and anti-goat antibodies (1:2500 dilution) were purchased from Amersham Inc and Pierce Inc, respectively. Detection was performed using the ECL-plus reagent (Amersham Biosciences Inc.) and quantitation was performed using the Scion Image software. Inc.) were used at a 1:1000 dilution.
RESULTS

Cholic Acid induces inflammatory gene expression. Previous studies have demonstrated
a dramatic induction of inflammatory gene expression in livers from mice fed a high fat diet containing CA (9, 18). Studies were undertaken to determine the involvement of cholate in mediating these inflammatory gene inductions. C57BL/6 mice were fed a chow, high fat diet supplemented with 0.5% cholate or high fat diet alone for 5 weeks.
Induction of the inflammatory genes ICAM-1, VCAM-1, SAA-2 and TNFα mRNA occurred in mice fed a high fat diet containing CA but not in mice fed a high fat diet without CA ( Figure 1 ). This suggests that the induction of these genes is dependent on CA.
To further prove the role of CA in the induction of these inflammatory genes and to eliminate the potential confounding toxic metabolic effects associated with 5-week exposure to CA (7), C57BL/6 mice were fed a chow diet supplemented with increasing concentrations of CA (0.01-1%) for 5 days. Real-time RT-PCR analysis demonstrated a dose-dependent induction in the hepatic mRNA levels of ICAM-1, VCAM-1, TNFα and SAA-2 with maximal induction observed at the 0.3% dose for TNFα (2-fold) and at 1.0%
for ICAM-1 (3.1-fold), VCAM-1 (2.2-fold) and SAA-2 (28-fold) (Fig. 2) . As positive controls, the induction of SHP and repression of CYP7A1 by CA was observed as previously reported (19). These data support the premise that bile acids such as CA can induce inflammatory gene expression in the liver.
FXR is required for the induction of ICAM-1 in HepG2 cells.
To further elucidate the role of bile acids in the induction of hepatic inflammatory genes, studies were performed in primary human hepatocytes and the human hepatic cell line, HepG2. Primary human hepatocytes were treated with 100 µM CDCA or 1 µM the synthetic FXR agonist GW4064 for 6 and 24 hours and the mRNA levels were determined by real-time RT-PCR. Both SHP and ICAM-1 were induced by CDCA and GW4064 treatment at both time points (Figure 3) . In contrast, SAA-2 mRNA levels were only slightly induced (1.4-fold) by GW4064 while VCAM-1 mRNA levels were not regulated at all (data not shown). To further study the regulation of ICAM-1 by FXR, HepG2 cells were treated with increasing concentrations of CDCA or GW4064 for 24 hours. ICAM-1 mRNA levels were dose-dependently increased by both CDCA and GW4064 treatment with the maximal fold induction of 2.7 and 2.5 at 100 µM CDCA and 100 nM GW4064, respectively ( Figure 4A ). Similar results were also obtained in the human hepatocyte cell line, Hep3B (data not shown). As expected, SHP mRNA was upregulated whereas CYP7A1 mRNA was downregulated by CDCA and GW4064 in a dose-dependent manner consistent with previous observations (16) . Time course studies demonstrated a rapid induction of ICAM-1 and SHP mRNA within 2 hr by GW4064 treatment and persisting for at least 24 hr ( Figure 4B ), which resulted in the induction of ICAM-1 protein levels (Fig. 4C) . The ability of the selective FXR agonist GW4064 to induce ICAM-1 expression supports the involvement of FXR signaling in mediating this effect.
To further confirm the role of FXR in the induction of ICAM-1, HepG2 cells were treated with 100 nM GW4064 alone or co-treated with 5 µM of the FXR-selective antagonist guggulsterone ( Figure 5A) (5, 35) . The GW4064 mediated elevation of SHP and ICAM-1 mRNA was effectively inhibited by guggulsterone co-administration. In addition, transfection of FXR siRNA resulted in a 50% suppression of endogenous FXR mRNA levels, which led to an approximate 50% decrease in the GW4064 mediated induction of SHP mRNA levels (from a 60% increase to a 30% increase over vehicle treated cells, Figure 5B) . A similar decrease in the GW4064 mediated induction in ICAM-1 expression was also observed following FXR siRNA transfection (from a 130% increase to a 60% increase over vehicle treated cells, Figure 5B ). These data further support a role for FXR in mediating ICAM-1 expression in HepG2 cells.
Mapping the FXR Responsive Element in the Human ICAM-1 Promoter.
To determine the mechanism of FXR regulation on ICAM-1, a series of promoter deletion constructs was created and tested in HepG2 co-transfection assays. As shown in Fig. 6, GW4064 treatment resulted in a 3-fold induction in luciferase activity with the ICAM-1 promoter construct containing sequences from -1127 to +18. Deletion of promoter sequences from -1127 to -309 did not affect the GW4064 mediated induction in luciferase activity.
However, deletion from -309 to -244 resulted in a complete loss of GW4064 mediated induction. The sequence between -309 to -244 contains a RARE (reviewed in(37)) and mutation of this site within the context of the -309 to +18 promoter region (see Fig 7A) also resulted in the loss of the FXR-mediated induction.
This RARE site appears to contain an imbedded FXRE site (Fig. 7A) . To 
Coordinative Induction of ICAM-1 Expression by FXR agonist and Pro-inflammatory
Cytokine. Since cytokine signaling can regulate genes involved in bile acid synthesis (6, 10) and is linked with inflammatory gene expression, we wanted to determine if there was any cooperation between bile acids and cytokines in influencing ICAM-1 expression.
From previous experiments, TNFα was shown to modulate ICAM-1 expression through the NF-κB element just downstream from the newly identified FXRE (4) and it is likely that these two signaling pathways may coordinately impact the ICAM-1 promoter. 
DISCUSSION
It has been well established that high doses of bile acids can induce inflammation in the liver and cause liver damage in disease conditions like primary biliary cirrhosis, cholestasis and primary sclerosing cholangitis (8). In this study, we determined that bile acids alone, in the absence of high fat and high cholesterol, could mediate the induction of a number of inflammatory genes in the mouse liver. In addition, we identified a novel role for FXR in being involved in this activity, specifically in mediating the induction of ICAM-1 in human hepatocytes. This induction of inflammatory gene expression is likely to initiate or contribute to bile acid induced inflammation.
Our study initiated from the observation of the increased expression of proinflammatory genes in the liver of C57BL/6 mice fed an atherogenic diet (20% fat, 0.15% cholesterol and 0.5% cholate) for 5 weeks (9). We demonstrate here that CA alone can mediate the induction of at least a subset of these pro-inflammatory genes such as VCAM-1, ICAM-1, TNFα and SAA-2. This is supported by a previous study in which the induction of VCAM-1 as well as other pro-inflammatory genes such as the chemokines scya6 and scya9 were attributed solely to the cholate component of the atherogenic diet (36). In that study, SAA-2 expression was also demonstrated to be induced by either the cholesterol or cholate component of the diet. Therefore, it appears that bile acids themselves are inducers of pro-inflammatory gene expression in the liver.
Through a series of in vitro experiments including agonist, antagonist and siRNA, we provide strong evidence that bile acids induce the expression of ICAM-1 through a FXR-dependent mechanism. Using promoter mapping and EMSA assays, we showed that FXR and RXR bind to a RARE/FXRE site within the promoter of ICAM-1. 
